221 related articles for article (PubMed ID: 1899564)
1. Substrate specificity of tissue-type and urokinase-type plasminogen activators.
Rijken DC; Groeneveld E
Biochem Biophys Res Commun; 1991 Jan; 174(2):432-8. PubMed ID: 1899564
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
Hajjar KA; Hamel NM
J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465
[TBL] [Abstract][Full Text] [Related]
3. Urokinase and tissue-type plasminogen activators are present in breast cyst fluids.
Macgregor IR; Miller WR
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):985-9. PubMed ID: 3137078
[TBL] [Abstract][Full Text] [Related]
4. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
[TBL] [Abstract][Full Text] [Related]
5. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
[TBL] [Abstract][Full Text] [Related]
6. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
Bizik J; Lizonová A; Stephens RW; Grófová M; Vaheri A
Cell Regul; 1990 Nov; 1(12):895-905. PubMed ID: 1712633
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of a plasma factor which cleaves single-chain form of t-PA and u-PA.
Okada K; Fukao H; Tanaka H; Ueshima S; Matsuo O
Thromb Res Suppl; 1990; 10():27-43. PubMed ID: 2156352
[TBL] [Abstract][Full Text] [Related]
9. Biological properties of hybrid plasminogen activators.
Hung PP; Wilhelm J; Kalyan NK; Cheng SM; James HL; Nachowiak D; Weinheimer CJ; Sobel BE; Bergmann SR; Lee SG
Adv Exp Med Biol; 1990; 281():201-8. PubMed ID: 2129369
[TBL] [Abstract][Full Text] [Related]
10. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
11. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158.
Nelles L; Lijnen HR; Collen D; Holmes WE
J Biol Chem; 1987 Apr; 262(12):5682-9. PubMed ID: 3106341
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of human urokinase-type plasminogen activator.
Barlati S; Paracini F; Bellotti D; De Petro G
FEBS Lett; 1991 Apr; 281(1-2):137-40. PubMed ID: 1901800
[TBL] [Abstract][Full Text] [Related]
14. A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.
Reboud-Ravaux M; Vilain AC; Boggetto N; Maillard J; Favreau C; Xie J; Mazaleyrat JP; Wakselman M
Biochem Biophys Res Commun; 1991 Jul; 178(1):352-9. PubMed ID: 1829886
[TBL] [Abstract][Full Text] [Related]
15. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
Berkenpas MB; Quigley JP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7768-72. PubMed ID: 1652763
[TBL] [Abstract][Full Text] [Related]
16. Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.
Booyse FM; Scheinbuks J; Lin PH; Traylor M; Bruce R
J Biol Chem; 1988 Oct; 263(29):15129-38. PubMed ID: 3139666
[TBL] [Abstract][Full Text] [Related]
17. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
[TBL] [Abstract][Full Text] [Related]
18. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
[TBL] [Abstract][Full Text] [Related]
19. Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.
Krause J; Seydel W; Heinzel G; Tanswell P
Biochem J; 1990 May; 267(3):647-52. PubMed ID: 2160232
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activation system in human milk.
Heegaard CW; Larsen LB; Rasmussen LK; Højberg KE; Petersen TE; Andreasen PA
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):159-66. PubMed ID: 9252902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
